• MY CART    0

    Your cart is currently empty.

Please Call Us:

Free Shipping On Purchases Over $75 (US Only)

Customer Service:

Please Call Us:


CBD May Help Manage Schizophrenia and Psychosis

CBD May Help Manage Schizophrenia and Psychosis

CBD, acting in a way that is the exact opposite to THC, has been found to be potentially ideal for treating psychoses such as schizophrenia. This post from Cantech Letter highlights the Canadian study that found that the marijuana-based chemical can treat schizophrenia.

A new study from Western University concludes that a chemical found in marijuana can be useful in the treatment of schizophrenia.

The study, led by Justine Renard, postdoctoral fellow in Western’s Department of Anatomy and Cell Biology at the Schulich School of Medicine and Dentistry, identifies the neural pathway whereby the cannabis-derived phytochemical cannabidiol (CBD) produces antipsychotic effects that are found to reduce symptoms of schizophrenia-related psychosis.

“These findings have critical implications not only for understanding how specific phytochemical components of marijuana may differentially impact neuropsychiatric phenomena, but demonstrate a potential mechanism for the therapeutic effects of marijuana derivatives in the treatment of dopamine-related, psychiatric disorders,” say the study’s authors.

Marijuana contains two main chemicals responsible for producing its psychoactive properties -the more well-known THC or tetrahydrocannabinol and CBD. And while THC serves to produce the drug’s psychoactive properties, CBD has been found to have an opposing, antipsychotic effect, which makes it potentially ideal for use in treatment of psychoses such as schizophrenia. The link between marijuana and schizophrenia has been known for some time, as studies have shown that heavy marijuana use, particularly in adolescence, increases the risk of developing schizophrenia and that schizophrenics who use marijuana are more liable to have worsening symptoms and further progression of the illness. But recent evidence including the work done at the Western University lab points to THC as the culprit rather than CBD.

“CBD is acting in a way that is the exact opposite to what THC is doing,” says co-author Steven Laviolette. “Within the same plant, you’ve got two different chemicals that are producing opposite effects in terms of psychiatric effects, molecular signaling and effects on the dopamine pathway.”

Researchers injected rats with CBD to study its behavioural, chemical and neuropathic effects and found that it serves to reduce dopamine sensitization -a response that has been linked to schizophrenia-related psychoses. This helps to explain exactly how CBD affects brain functioning (an unknown up to this point) but it also points to a novel approach for treating psychoses, something researchers say is sorely needed.

Source: PUF Ventures Inc. (CSE:PUF).

More Posts

Related Posts


Leave a comment

All blog comments are checked prior to publishing

An Offer for you!

Join our Mailing List

Sign up to receive our email updates

Search our store